GEROSCIENCE

Clinical trials for GEROSCIENCE explained in plain language.

Never miss a new study

Get alerted when new GEROSCIENCE trials appear

Sign up with your email to follow new studies for GEROSCIENCE, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 1

Can a daily pill slow aging? new trial tests GLYLO supplement in postmenopausal women

Disease control Recruiting now

This pilot study tests whether a dietary supplement called GLYLO can lower harmful compounds called AGEs in overweight or obese postmenopausal women aged 45-65. Participants take either GLYLO or a placebo for 24 weeks, and researchers measure changes in AGEs, insulin resistance, …

Matched conditions: GEROSCIENCE

Phase: NA • Sponsor: Buck Institute for Research on Aging • Aim: Disease control

Last updated Jun 26, 2026 15:12 UTC

GEROSCIENCE

Get alerted when new GEROSCIENCE trials appear

Can a daily pill slow aging? new trial tests GLYLO supplement in postmenopausal women